Coexpression of Dopamine and Somatostatin Receptor Subtypes in Corticotroph Adenomas
The DOI matches its Crossref record.
Abstract
Context: Previous studies have demonstrated the expression of somatostatin receptor subtypes (mainly sst5) and dopamine (DA) receptor subtypes (mainly D2) in smaller series of human corticotroph adenomas. In line with these findings, sst5 and D2-targeting agents have already been used clinically in patients with Cushing’s disease (CD) and have shown promising results in subsets of patients. To what extent these receptor subtypes are coexpressed within individual adenomas, is not known however. Objective: The aim of the study was to investigate the (co-)expression of both sst and DA receptors in a large series of human corticotroph adenomas. Design: We performed in vitro analysis of corticotroph adenoma tissue obtained via transsphenoidal adenomectomy. Setting: The study was conducted at two university medical centers. Patients: Adenoma tissue from 30 patients with CD was analyzed in this study. Results: Analyzed by quantitative RT-PCR, D2 and sst5 were significantly (co-) expressed in the majority (60%) of adenomas, whereas 23% of adenomas only expressed D2, but not sst5. The remaining 17% of adenomas did not significantly express either sst5 or D2. Overall, expression of sst1–4 and D4 was low to nondetectable. Corticotroph adenomas with invasive growth invariably showed loss of sst5 and D2 expression. Autoradiography revealed clear D2 and/or SS-14 binding in a subset of cases, which correlated well with their respective mRNA data. Conclusions: Sst5 and especially D2 are highly expressed in the majority of human corticotroph adenomas, with coexpression of sst5 and D2 being a common phenomenon. These findings support the current studies with sst5 and D2-targeting agents in patients with CD and highlight the rationale behind sst5-D2 combination therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Self-citationTreatment of Cushing's syndrome: an Endocrine Society clinical practice guideline
Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., & Tabarin, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1818 · Cited by 1,270
Somatostatin receptors: From signaling to clinical practice
Theodoropoulou, M., & Stalla, G. K. (2013) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.07.005 · Cited by 410
Pasireotide Alone or with Cabergoline and Ketoconazole in Cushing's Disease
Feelders, R. A., de Bruin, C., Pereira, A. M., Romijn, J. A., Netea-Maier, R. T., Hermus, A. R., Zelissen, P. M., van Heerebeek, R., de Jong, F. H., van der Lely, A.-J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmc1000094 · Cited by 262
Self-citationGünther, T., Tulipano, G., Dournaud, P., Bousquet, C., Csaba, Z., Kreienkamp, H.-J., Lupp, A., Korbonits, M., Castaño, J. P., Wester, H.-J., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015388 · Cited by 253
Metadata
- Authors
- de Bruin, C., Pereira, A. M., Feelders, R. A., Romijn, J. A., Roelfsema, F., Sprij-Mooij, D. M., van Aken, M. O., van der Lelij, A.-J., de Herder, W. W., Lamberts, S. W. J., & Hofland, L. J.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2009-04-01
- Volume
- 94
- Issue
- 4
- Pages
- 1118-1124
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2168291388
- Cited by
- 124
- References
- 0
- FWCI
- 8.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Coexpression of Dopamine and Somatostatin Receptor Subtypes in Corticotroph Adenomas. https://app.cochat.ai/papers/10.1210/jc.2008-2101
- The paper
- de Bruin, C., Pereira, A. M., Feelders, R. A., Romijn, J. A., Roelfsema, F., Sprij-Mooij, D. M., van Aken, M. O., van der Lelij, A.-J., de Herder, W. W., Lamberts, S. W. J., & Hofland, L. J. (2009). Coexpression of Dopamine and Somatostatin Receptor Subtypes in Corticotroph Adenomas. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2008-2101
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.